COVID-19 · PLoS Pathog · 2021
Summary says COVID-19 patients’ liver-damage marker was lower than healthy people’s. The paper’s own table: higher.
ALT in patients vs healthy people, lab units (healthy limit: 40 men, 35 women)
The paper says
The study compared 438 COVID-19 patients with no other illness to 369 healthy people, each split into four groups: younger men, younger women, older men, older women. Its summary says patients in all four had “lower” ALT, which damaged liver cells leak into the blood.
Its own data show
In the paper’s own results table, the typical patient had more ALT than the typical healthy person in every group, and patients were 3.4 to 8.6 times as likely to be over the healthy limit. For typical levels, the paper’s tests make chance unlikely in younger people but possible in the smaller older groups.
ALT (alanine aminotransferase) is a protein that leaks from damaged liver cells into the blood, so more ALT is a sign of liver damage. The paper’s results text agrees with its table, and its discussion says the infection “damages liver function”. Only one sentence of the summary, the part most people read, points the opposite way.